Retraction
Lapatinib, a Dual Inhibitor of Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor 2, Potentiates the Antitumor Effects of Cisplatin on Esophageal Carcinoma
Paper Information
Record ID:
4389
Journal:
Publication Date:
July 01, 2013
Retraction Date:
November 01, 2014
(11.1 years years ago)
Subjects:
Institution:
The First Affiliated Hospital of Xinxiang Medical University, Weihui, Henan Province, ChinaCountry:
🇨🇳 ChinaArticle Type:
Publisher:
Oxford Academic
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Citations (8)
8
Total Citations4
Post-Retraction(50.0%)
3
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
2
Within 1 year
1
After 2+ years
949
Days since retraction (latest)
Paper citing Lapatinib, a Dual Inhibitor of Epidermal Growth Fa...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Lapatinib, a Dual Inhibitor of Epidermal Growth Fa...
Unknown Authors
Unknown Journal
Published: Jun 2017
949 days after retraction
Paper citing Lapatinib, a Dual Inhibitor of Epidermal Growth Fa...
Unknown Authors
Unknown Journal
Published: Feb 2016
475 days after retraction
Paper citing The Rational Design of Specific Peptide Inhibitor ...
Unknown Authors
Unknown Journal
Published: Jul 2015
254 days after retraction
Paper citing Lapatinib, a Dual Inhibitor of Epidermal Growth Fa...
Unknown Authors
Unknown Journal
Published: Apr 2015
177 days after retraction
Paper citing Lapatinib, a Dual Inhibitor of Epidermal Growth Fa...
Unknown Authors
Unknown Journal
Published: Jul 2014
109 days before retraction
Paper citing Lapatinib, a Dual Inhibitor of Epidermal Growth Fa...
Unknown Authors
Unknown Journal
Published: Dec 2012
687 days before retraction
Paper citing Lapatinib, a Dual Inhibitor of Epidermal Growth Fa...
Unknown Authors
Unknown Journal
Published: Nov 2012
715 days before retraction
Quick Stats
Total Citations:
8
Years Since Retraction:
11.1 years
Open Access:
Yes
Last Checked:
Never